Extended safety check for dry eye combo drug halted
NCT ID NCT07111013
Summary
This study was designed to check the long-term safety of a combination eye drop (lifitegrast/perfluorohexyloctane) for people with dry eye disease. It was meant to last 12 months and was only open to people who had successfully completed a specific earlier trial. However, the study was withdrawn and did not enroll any participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.